Companies: 10,795·Total market cap: $144.5T
Invivyd, Inc.

Invivyd, Inc.

IVVDNASDAQHealthcare● Active
$1.02
$-0.01(-0.97%)
Market Cap$135384031
P/E Ratio
52W High$3.07
52W Low$0.483

Invivyd, Inc. (IVVD) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

ivvd · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Invivyd, Inc. (IVVD) measures how much investors pay for each dollar of the company's trailing earnings. IVVD's current PE ratio of N/A is calculated by dividing its stock price of $1.02 by its TTM earnings per share of -$0.25.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.28
Based on 1 analyst
EPS (TTM)
-$0.25
TTM · diluted EPS
PEG Ratio
-0.03
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Invivyd, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2020 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Invivyd, Inc.
Invivyd, Inc.You
IVVD
$135MN/A-$0.25
C4 Therapeutics, Inc.
C4 Therapeutics, Inc.
CCCC
$297MN/A-$1.27
Codexis, Inc.
Codexis, Inc.
CDXS
$237MN/A-$0.50
Genfit S.A.
Genfit S.A.
GNFT
$446M119.75x$0.03
Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc.
IMDX
$154MN/A-$1.65
Neonc Technologies Holdings, Inc.
Neonc Technologies Holdings, Inc.
NTHI
$90MN/A-$3.23
OmniAb, Inc.
OmniAb, Inc.
OABI
$272MN/A-$0.57

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.30
2024-12-31
FY2024
$-1.43
2023-12-31
FY2023
$-1.81
2022-12-31
FY2022
$-2.23
2021-12-31
FY2021
$-2.05
2020-12-31
FY2020
$-1.01

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Invivyd, Inc. (IVVD) measures how much investors pay for each dollar of the company's trailing earnings. IVVD's current PE ratio of N/A is calculated by dividing its stock price of $1.02 by its TTM earnings per share of -$0.25.

PE Ratio = Stock Price ÷ EPS (TTM)
= $1.02 ÷ -$0.25 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

IVVD pe ratio · 6 questions

IVVD's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.02 and TTM EPS of -$0.25. Data sourced from Financial Modeling Prep via IVVD's SEC 10-K and 10-Q filings.

IVVD PE ratioWhat is IVVD PE ratioCurrent PE ratio of IVVDIVVD PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Invivyd, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08